SCHEMBL5685703

SCHEMBL5685703

CCCc1c(N)cccc1C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.42
HSD17B10 Q99714 6/20 0.42
PARP1 P09874 4/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
NR1I2 O75469 1/20 0.41
CHRM2 P08172 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADRA2A P08913 1/20 0.41
OPRK1 P41145 1/20 0.41
HTR2B P41595 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KMT2A Q03164 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
KDM4E B2RXH2 6/20 0.40
HPGD P15428 3/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.39
PARP2 Q9UGN5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6258469 0.90 ALDH1A1 (0.46) ALDH1A1HSD17B10PARP1LMNAMAPT
SCHEMBL2964481 0.89 PARP1 (0.45) ALDH1A1HSD17B10PARP1LMNAMAPT
SCHEMBL10903924 0.88 CYP3A4 (0.48) ALDH1A1HSD17B10PARP1LMNAMAPT
SCHEMBL5135888 0.86 MMP2 (0.52) ALDH1A1HSD17B10MAPTKDM4EHPGD
SCHEMBL3622851 0.85 PARP1 (0.46) ALDH1A1HSD17B10PARP1LMNAMAPT
Hydrochloric Acid SCHEMBL28057982 0.84 PARP1 (0.45) ALDH1A1HSD17B10PARP1LMNAMAPT
SCHEMBL3352032 0.82 PARP1 (0.41) ALDH1A1HSD17B10PARP1LMNAMAPT
SCHEMBL4235369 0.82 CXCR5 (0.49) ALDH1A1HSD17B10PARP1LMNAMAPT
SCHEMBL21439307 0.81 MAPK8 (0.44) ALDH1A1HSD17B10PARP1LMNAMAPT
SCHEMBL5481197 0.81 PARP1 (0.40) ALDH1A1HSD17B10PARP1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1615892-A2 BENZAMIDE 2-HYDROXY-3-DIAMINOALKANES Elan Pharmaceuticals, Inc. (US) 2006-01-18 EP disclosed
WO-2004094384-A2 (HETERO) ARYLAMIDE 2-HYDROXY-3-DIAMINOALKANES FOR USE IN THE TREATMENT OF ALZHEIMER’S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2004-11-04 WO disclosed